Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Jean-Guillaume Dillinger; Boris Aleil; Saida Cheggour; Ygal Benhamou; Yannick Béjot; Sylvestre Marechaux; Aurélien Delluc; Laurent Bertoletti; Nicolas Lellouche

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Jean-Guillaume Dillinger ¹ Boris Aleil ² Saida Cheggour Ygal Benhamou ³ Yannick Béjot ⁴ Sylvestre Marechaux ⁵ Aurélien Delluc ⁶ Laurent Bertoletti ⁷ Nicolas Lellouche ⁸

1 Hôpital Lariboisière

2 Biologie et pharmacologie de l'hémostase et de la thrombose

3 Service de Médecine Interne [Rouen]

4 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand

5 Groupement Hospitalier de l'Institut Catholique de Lille

6 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

7 GRT (EA 3065) - Groupe de recherche sur la thrombose

8 IMRB - Institut Mondor de recherche biomédicale

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Human health and pathology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Complete list of metadatas

https://hal.univ-brest.fr/hal-02055852
Contributor : Ghislaine Calvez <>
Submitted on : Monday, March 4, 2019 - 12:12:42 PM
Last modification on : Friday, October 4, 2019 - 1:35:07 AM

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Identifiers

Collections

Citation

Export

Metrics

37

Contact

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Identifiers

Collections

Citation

Export

Share

Metrics

37

Contact